Medicare Enrolled
Dr. Matthew Steele, MD
Urology Physician · Watkinsville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Steele from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Steele?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Steele
Dr. Matthew Steele is an urology physician in Watkinsville, GA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Steele performed 4,096 Medicare services across 2,832 unique beneficiaries.
Between the years covered by Open Payments, Dr. Steele received a total of $5,784 from 63 pharmaceutical and/or device companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Steele is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 24% volume in GA
$5,784 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,096
Medicare services
Top 24% in GA for urology physician
2,832
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~256 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
700 | $87 | $240 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
666 | $3 | $33 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
664 | $2 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
493 | $61 | $198 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
332 | $7 | $60 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 207 | $133 | $442 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
198 | $39 | $305 |
| Abdominal X-ray, 2 views An X-ray imaging test of the abdomen using two different angles to visualize internal structures. |
145 | $24 | $110 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
127 | $152 | $625 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
81 | $48 | $92 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
65 | $25 | $210 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
61 | $114 | $375 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
60 | $62 | $260 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
51 | $36 | $62 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
36 | $101 | $302 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
30 | $74 | $266 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
26 | $17 | $55 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
21 | $125 | $2,099 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
20 | $47 | $80 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
17 | $101 | $450 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
14 | $257 | $1,060 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
14 | $5 | $100 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
14 | $24 | $580 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
14 | $141 | $495 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $139 | $835 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
14 | $44 | $575 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
12 | $75 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
15.9% medium
83.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,784
Total received (2018-2024)
Avg $826/year across 7 years
Top 39% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
317
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,685 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$921
2023
$552
2022
$694
2021
$881
2020
$587
2019
$936
2018
$1,214
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$172
C. R. Bard, Inc. & Subsidiaries
$118
ABBVIE INC.
$106
Sumitomo Pharma America, Inc.
$95
Ferring Pharmaceuticals Inc.
$73
Janssen Biotech, Inc.
$60
Myriad Genetic Laboratories, Inc.
$58
Bayer Healthcare Pharmaceuticals Inc.
$53
Astellas Pharma US Inc
$37
Boston Scientific Corporation
$31
Dendreon Pharmaceuticals LLC
$27
Axonics, Inc.
$23
Agiliti Surgical, Inc.
$20
CIVCO Medical Instruments
$17
Calyxo, Inc.
$16
Verity Pharmaceuticals Inc.
$15
Top 3 companies account for 43.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$961
Janssen Biotech, Inc.
$422
Dendreon Pharmaceuticals LLC
$313
Endo Pharmaceuticals Inc.
$263
Myriad Genetic Laboratories, Inc.
$230
Bayer HealthCare Pharmaceuticals Inc.
$210
Teleflex LLC
$203
Amgen Inc.
$198
Blue Earth Diagnostics Limited
$173
Boston Scientific Corporation
$173
Sumitomo Pharma America, Inc.
$167
PFIZER INC.
$160
Bayer Healthcare Pharmaceuticals Inc.
$142
ABBVIE INC.
$130
Intuitive Surgical, Inc.
$128
Ferring Pharmaceuticals Inc.
$125
C. R. Bard, Inc. & Subsidiaries
$118
MEDIVATION FIELD SOLUTIONS LLC
$112
TOLMAR Pharmaceuticals, Inc.
$110
AbbVie Inc.
$108
Novartis Pharmaceuticals Corporation
$91
AbbVie, Inc.
$86
Rochester Medical Corporation
$81
Janssen Products, LP
$60
Myovant Sciences Inc.
$60
Avadel Specialty Pharmaceuticals, LLC
$59
UroGen Pharma, Inc.
$58
UROGEN PHARMA, INC.
$57
Allergan Inc.
$44
Travere Therapeutics, Inc.
$44
Coloplast Corp
$42
PROCEPT BioRobotics Corporation
$38
Alnylam Pharmaceuticals Inc.
$34
AngioDynamics, Inc.
$34
AstraZeneca Pharmaceuticals LP
$33
Laborie Medical Technologies Corp.
$32
Ambu Inc.
$28
BOSTON SCIENTIFIC CORPORATION
$27
Retrophin, Inc.
$26
Allergan, Inc.
$24
NeoTract Inc.
$24
Abbott Laboratories
$24
Axonics, Inc.
$23
Tolmar, Inc.
$21
Merck Sharp & Dohme LLC
$20
Egalet US Inc
$20
Antares Pharma, Inc.
$20
Agiliti Surgical, Inc.
$20
CIVCO Medical Instruments
$17
TherapeuticsMD, Inc.
$16
Calyxo, Inc.
$16
Wilmington Medical Supply, Inc.
$16
BAUDAX BIO INC.
$15
Verity Pharmaceuticals Inc.
$15
Cumberland Pharmaceuticals, Inc.
$15
Sun Pharmaceutical Industries Inc.
$15
Olympus America Inc.
$14
Biocompatibles, Inc.
$13
Mission Pharmacal Company
$13
ROCHESTER MEDICAL CORPORATION
$13
AMAG Pharmaceuticals, Inc.
$12
Metuchen Pharmaceuticals
$11
C. R. BARD, INC. & SUBSIDIARIES
$6
Top 3 companies account for 29.3% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AFINITOR · AMS 700 CXR RTE KIT · ANJESO · AQUABEAM ROBOTIC SYSTEM · Advantage System · Androgel · AquaBeam Robotic System · Axumin · BOTOX · Bard Urinary Drainage Bag · Bulkamid · CALDOLOR · CVAC ASPIRATION SYSTEM · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL PELVIC ORGAN PROLAPSE · GENTLECATH · GREENLIGHT · IMVEXXY · INTRAROSA · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NANOKNIFE · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · PROLARIS · PROVENGE · Proclaim Family of SCS IPGs · Proclaim IPG · Prolaris · REZUM · SPACEOAR · SPEEDICATH · SPRIX · Sonablate HIFU · Stendra · TOVIAZ · Thiola · Trelstar · Uribel · UroLift · UroLift System · VISUAL-ICE · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
13
Per 100K population
30.4
County median income
$115,925
Nearest hospital
ST MARY'S HOSPITAL
11.4 mi
11.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Steele is a clinical cardiology specialist, with above-average Medicare volume (top 24% in GA), with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Steele experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Steele performed 700 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Steele receive payments from pharmaceutical companies?
Yes. Dr. Steele received a total of $5,784 from 63 companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Steele's costs compare to other urology physicians in Watkinsville?
Dr. Steele's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Steele) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Watkinsville
Browse urology physicians in Watkinsville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology